Thrombus structure and composition are the main determinants of the severity, course, and outcomes of thrombosis. Detailed thrombus morphology has become available due to mechanical thrombectomy, which allows for the extraction of fresh thrombi from patients, followed by scanning electron microscopy. The major structural elements of a thrombus are platelets, erythrocytes, and fibrin, each playing a critical role in the determination of biological and physical properties of thrombi, such as permeability, stiffness, and lytic and mechanical stability. The minor components include neutrophils, monocytes, von Willebrand factor, cellular microvesicles, plasma proteins, cholesterol crystals, and other structures. Platelets are responsible for the contraction (retraction) of thrombi, which results in compaction with very little free space, low permeability, and high stiffness. Because of clot contraction, erythrocytes, which are prevalent in all types of thrombi, undergo compressive deformation to polyhedral (polyhedrocytes) and polyhedral-like cells, altogether comprising pressure-deformed cells (piezocytes). Fibrin is the structural and mechanical scaffold of thrombi that changes in time and space both quantitatively and qualitatively during their formation. Fibrin is an equilibrium polymer that can adapt to forced deformations by reorientation at the microscopic level and unfolding at the molecular level. The relative volume fractions of thrombus components, along with their functional and structural forms, vary substantially, providing a basis for the diverse pathogenic mechanisms and clinical manifestations of thrombosis. Modulating any of these components leads to prospective therapeutic approaches. This review summarizes recent research describing the quantitative and qualitative morphologic characteristics of arterial and venous thrombi, which provide a basis for new therapeutic opportunities in thrombosis.
Skip Nav Destination
THE STRUCTURAL UNDERPINNINGS OF HEMOSTATIC PLUGS AND THROMBOTIC OCCLUSIONS|
September 18, 2025
Exploring the thrombus niche: lessons learned and potential therapeutic opportunities Available to Purchase
John W. Weisel,
John W. Weisel
Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for other works by this author on:
Rustem I. Litvinov
Rustem I. Litvinov
Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Search for other works by this author on:
Blood (2025) 146 (12): 1389–1399.
Article history
Submitted:
November 5, 2024
Accepted:
January 28, 2025
First Edition:
February 28, 2025
Connected Content
A related article has been published:
Platelet activation and signaling in thrombus formation
A related article has been published:
Factor XIII: driving (cross-)links in hemostasis, thrombosis, and disease
A related article has been published:
Structure-based design of therapeutics to control hemostasis
A related article has been published:
Structure and interactions of the proteins from the contact system
A related article has been published:
Introduction to a review series on the structural underpinnings of hemostatic plugs and thrombotic occlusions
Citation
John W. Weisel, Rustem I. Litvinov; Exploring the thrombus niche: lessons learned and potential therapeutic opportunities. Blood 2025; 146 (12): 1389–1399. doi: https://doi.org/10.1182/blood.2024025319
Download citation file:
My Account
Sign In
September 18 2025
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal